Free Republic

Key Points Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing for approval of the weekly injection, called retatrutide, which works differently from existing injections and pills. The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over 80 weeks. ==================================================================== VIDEO AT LINK........ Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring...

Beloved FReeper FRiends, please keep me in your prayers for healing. I’ve been suffering quite the bout of gastrointestinal malady, including nausea. I am doing my best to keep my potassium levels up, stay hydrated and keep my blood sugar up. I am keeping a close eye on things and if necessary go to my local ER for evaluation/treatment. I KNOW MY REDEEMER LIVES. AND I KNOW HE HEALS. Thank you my Dear Ones in CHRIST JESUS OUR LORD AND SAVIOR.

Beloved FRiends, please lift my dear husband, John, up in prayer. He is suffering from gastrointestinal bleeding, pain and has lost a lot of weight. His doctor has tended to polyps and other lower intestinal maladies, but the bleeding has returned. He is weak, tired and of course afraid. But I know his Redeemer Lives.

A research team led by Prof. Liu Qingsong and Liu Jing from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) has recently found that nintedanib, a multikinase inhibitor of the receptor tyrosine kinase FGFR/VEGFR/PDGFR, could be used in the treatment of drug-resistant gastrointestinal stromal tumors (GISTs). Results were published in Molecular Oncology. GISTs are mesenchymal tumors that usually occur in the gastrointestinal tract. Nearly 85% of GISTs bear oncogenic mutations in mast/stem cell growth factor receptor (KIT). As the first-line therapy, imatinib has significantly improves GIST patient survival. However, most patients eventually experience disease...

Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal epithelial cells. Since there are currently no coded therapies or guidelines for treatment of COVID-19, this study aimed to evaluate the possible role of a specific oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Methods: We provide a report of 70 patients positive for COVID-19, hospitalized between March 9th and April 4th, 2020. All the patients had fever, required non-invasive oxygen therapy and presented a CT lung involvement on imaging more than 50%....

The National Guard's deployment in Washington, D.C. will end Sunday after troops were called to the Capitol following the Jan. 6 riot. More than 2,000 National Guard troops are set to return to their home bases this week after the Department of Defense did not request an extended stay for the force to guard the nation’s capital. Capt. Chelsi B. Johnson of the D.C. National Guard Public Affairs told WUSA 9 that operations will “return to normal.” The Capitol Police have not requested the Guard to stay past May 23. Once the mission concludes, D.C. National Guard will return to...

Researchers Who Provided Key Evidence For Gluten Sensitivity Have Now Thoroughly Shown That It Doesn't Exist Jennifer WelshMay 15, 2014, 3:37 PMIn one of the best examples of science working, a researcher who provided key evidence of (non-celiac disease) gluten sensitivity recently published follow-up papers that show the opposite. The first follow-up paper came out last year in the journal Gastroenterology. Here's the backstory that makes us cheer: The study was a follow up on a 2011 experiment in the lab of Peter Gibson at Monash University. The scientifically sound — but small — study found that gluten-containing diets can...

A first-aid kit found on a 2,000-year-old shipwreck has provided a remarkable insight into the medicines concocted by ancient physicians to cure sailors of dysentery and other ailments. A wooden chest discovered on board the vessel contained pills made of ground-up vegetables, herbs and plants such as celery, onions, carrots, cabbage, alfalfa and chestnuts – all ingredients referred to in classical medical texts. The tablets, which were so well sealed that they miraculously survived being under water for more than two millennia, also contain extracts of parsley, nasturtium, radish, yarrow and hibiscus. They were found in 136 tin-lined wooden vials...